Finally, these new bioinformatics and functional genomics studies will be the only way forward to understand how and why PACAP38 is neuroprotective in the brain for any meaningful development of a stroke therapy using PACAP38 or its analogs. The gene discussed is ADCYAP1; the disease is Stroke.